Abstract
Summary
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
LPI (LP Information)' newest research report, the “Genomics Biomarkers Industry Forecast” looks at past sales and reviews total world Genomics Biomarkers sales in 2022, providing a comprehensive analysis by region and market sector of projected Genomics Biomarkers sales for 2023 through 2029. With Genomics Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genomics Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Genomics Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genomics Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genomics Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genomics Biomarkers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genomics Biomarkers.
The global Genomics Biomarkers market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomics Biomarkers market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Oncology
Cardiovascular Diseases
Neurological Diseases
Segmentation by application
Diagnostic and Research Laboratories
Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
LPI (LP Information)' newest research report, the “Genomics Biomarkers Industry Forecast” looks at past sales and reviews total world Genomics Biomarkers sales in 2022, providing a comprehensive analysis by region and market sector of projected Genomics Biomarkers sales for 2023 through 2029. With Genomics Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genomics Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Genomics Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genomics Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genomics Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genomics Biomarkers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genomics Biomarkers.
The global Genomics Biomarkers market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomics Biomarkers market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Oncology
Cardiovascular Diseases
Neurological Diseases
Segmentation by application
Diagnostic and Research Laboratories
Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genomics Biomarkers Market Size 2018-2029
2.1.2 Genomics Biomarkers Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Genomics Biomarkers Segment by Type
2.2.1 Oncology
2.2.2 Cardiovascular Diseases
2.2.3 Neurological Diseases
2.3 Genomics Biomarkers Market Size by Type
2.3.1 Genomics Biomarkers Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Genomics Biomarkers Market Size Market Share by Type (2018-2023)
2.4 Genomics Biomarkers Segment by Application
2.4.1 Diagnostic and Research Laboratories
2.4.2 Hospitals
2.5 Genomics Biomarkers Market Size by Application
2.5.1 Genomics Biomarkers Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Genomics Biomarkers Market Size Market Share by Application (2018-2023)
3 Genomics Biomarkers Market Size by Player
3.1 Genomics Biomarkers Market Size Market Share by Players
3.1.1 Global Genomics Biomarkers Revenue by Players (2018-2023)
3.1.2 Global Genomics Biomarkers Revenue Market Share by Players (2018-2023)
3.2 Global Genomics Biomarkers Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genomics Biomarkers by Regions
4.1 Genomics Biomarkers Market Size by Regions (2018-2023)
4.2 Americas Genomics Biomarkers Market Size Growth (2018-2023)
4.3 APAC Genomics Biomarkers Market Size Growth (2018-2023)
4.4 Europe Genomics Biomarkers Market Size Growth (2018-2023)
4.5 Middle East & Africa Genomics Biomarkers Market Size Growth (2018-2023)
5 Americas
5.1 Americas Genomics Biomarkers Market Size by Country (2018-2023)
5.2 Americas Genomics Biomarkers Market Size by Type (2018-2023)
5.3 Americas Genomics Biomarkers Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genomics Biomarkers Market Size by Region (2018-2023)
6.2 APAC Genomics Biomarkers Market Size by Type (2018-2023)
6.3 APAC Genomics Biomarkers Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genomics Biomarkers by Country (2018-2023)
7.2 Europe Genomics Biomarkers Market Size by Type (2018-2023)
7.3 Europe Genomics Biomarkers Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genomics Biomarkers by Region (2018-2023)
8.2 Middle East & Africa Genomics Biomarkers Market Size by Type (2018-2023)
8.3 Middle East & Africa Genomics Biomarkers Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Genomics Biomarkers Market Forecast
10.1 Global Genomics Biomarkers Forecast by Regions (2024-2029)
10.1.1 Global Genomics Biomarkers Forecast by Regions (2024-2029)
10.1.2 Americas Genomics Biomarkers Forecast
10.1.3 APAC Genomics Biomarkers Forecast
10.1.4 Europe Genomics Biomarkers Forecast
10.1.5 Middle East & Africa Genomics Biomarkers Forecast
10.2 Americas Genomics Biomarkers Forecast by Country (2024-2029)
10.2.1 United States Genomics Biomarkers Market Forecast
10.2.2 Canada Genomics Biomarkers Market Forecast
10.2.3 Mexico Genomics Biomarkers Market Forecast
10.2.4 Brazil Genomics Biomarkers Market Forecast
10.3 APAC Genomics Biomarkers Forecast by Region (2024-2029)
10.3.1 China Genomics Biomarkers Market Forecast
10.3.2 Japan Genomics Biomarkers Market Forecast
10.3.3 Korea Genomics Biomarkers Market Forecast
10.3.4 Southeast Asia Genomics Biomarkers Market Forecast
10.3.5 India Genomics Biomarkers Market Forecast
10.3.6 Australia Genomics Biomarkers Market Forecast
10.4 Europe Genomics Biomarkers Forecast by Country (2024-2029)
10.4.1 Germany Genomics Biomarkers Market Forecast
10.4.2 France Genomics Biomarkers Market Forecast
10.4.3 UK Genomics Biomarkers Market Forecast
10.4.4 Italy Genomics Biomarkers Market Forecast
10.4.5 Russia Genomics Biomarkers Market Forecast
10.5 Middle East & Africa Genomics Biomarkers Forecast by Region (2024-2029)
10.5.1 Egypt Genomics Biomarkers Market Forecast
10.5.2 South Africa Genomics Biomarkers Market Forecast
10.5.3 Israel Genomics Biomarkers Market Forecast
10.5.4 Turkey Genomics Biomarkers Market Forecast
10.5.5 GCC Countries Genomics Biomarkers Market Forecast
10.6 Global Genomics Biomarkers Forecast by Type (2024-2029)
10.7 Global Genomics Biomarkers Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Genomics Biomarkers Product Offered
11.1.3 Roche Diagnostics Genomics Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 Myriad Genetics
11.2.1 Myriad Genetics Company Information
11.2.2 Myriad Genetics Genomics Biomarkers Product Offered
11.2.3 Myriad Genetics Genomics Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Myriad Genetics Main Business Overview
11.2.5 Myriad Genetics Latest Developments
11.3 QIAGEN
11.3.1 QIAGEN Company Information
11.3.2 QIAGEN Genomics Biomarkers Product Offered
11.3.3 QIAGEN Genomics Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 QIAGEN Main Business Overview
11.3.5 QIAGEN Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Genomics Biomarkers Product Offered
11.4.3 Thermo Fisher Scientific Genomics Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Information
11.5.2 Bio-Rad Laboratories Genomics Biomarkers Product Offered
11.5.3 Bio-Rad Laboratories Genomics Biomarkers Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bio-Rad Laboratories Main Business Overview
11.5.5 Bio-Rad Laboratories Latest Developments
12 Research Findings and Conclusion